Article info

Download PDFPDF

Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?
Free
  1. Correspondence to:
    Dr D Baeten, Department of Rheumatology, 0K12IB, Ghent University Hospital, De Pintelaan 185, 9000 Gent, Belgium;
    dominique.baeten{at}ugent.be
View Full Text

Citation

Baeten D, Kruithof E, Van den Bosch F, et al
Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?

Publication history

  • Accepted May 12, 2003
  • First published August 15, 2003.
Online issue publication 
August 15, 2003

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.